*By Carlo Versano*
Federal regulators have subpoenaed Snap as part of a probe into its 2017 initial public offering, the company confirmed in a statement to Cheddar.
Reuters first [reported](https://www.reuters.com/article/us-snap-sec-exclusive/exclusive-snap-reveals-us-subpoenas-on-ipo-disclosures-idUSKCN1NJ04O) the subpoenas late Tuesday.
The subpoenas, filed by the Justice Dept. in coordination with the SEC, are believed to be related to a class action lawsuit filed by a group of investors in May 2017 that alleged the company misrepresented how competition from Facebook's Instagram ($FB) was affecting its growth ahead of the $3.4 billion IPO, and misled the public about its user metrics.
In the statement, Snap said: “While we do not have complete visibility into these investigations, our understanding is that the DOJ is likely focused on IPO disclosures relating to competition from Instagram."
The social-messaging app has suffered from the competition with Instagram, which launched a near-identical feature to Snapchat's core service in 2016 and now [boasts](https://money.cnn.com/2018/06/28/technology/instagram-stories-users/index.html) double the users. The company has also seen some of its top talent leave, including [most recently](https://www.cheddar.com/videos/snap-vp-content-nick-bell-to-leave) the head of content, Nick Bell.
Snap stock is trading at less than half its IPO price.
Seth Schachner, Managing Director at Strat Americas, on Hollywood's latest blockbusters utilizing content creation. Plus, the future of YouTube and TikTok.
Ashley Gold, Axios' Tech/Policy reporter, discusses what the future of Google and search engines will look like after the tech giant faces an antitrust trial.
A labor rights group has alleged that Starbucks sourced coffee from a major Brazilian cooperative whose member farms were cited for keeping workers in slave-like conditions.
X, the social media platform owned by Trump adviser Elon Musk, is challenging the constitutionality of a Minnesota ban on using deepfakes to influence elections and harm candidates.
Seth Goldstein, Equity Strategist at Morningstar, breaks down Tesla's earnings report, talks Musk's future with the company and how stocks have responded.
Senior Health Correspondent for TIME, Alice Park, gives us a deeper look into how Eli Lilly's new pill orforglipron may change the healthcare industry.
